[Oral contraceptives and acne vulgaris].
D000152:Acne Vulgaris / Q000139:chemically induced / Q000188:drug therapy / Q000503:physiopathology*; D000728:Androgens / Q000378:metabolism*; D003534:Cyproterone / Q000627:therapeutic use; D004967:Estrogens / Q000378:metabolism* / Q000494:pharmacology; D005260:Female; D006801:Humans; D008234:Lynestrenol / Q000009:adverse effects; D008297:Male; D011372:Progestins / Q000378:metabolism* / Q000494:pharmacology; D012627:Sebaceous Glands / Q000187:drug effects; D012629:Sebum / Q000378:metabolism
D000728:Androgens; D004967:Estrogens; D011372:Progestins; D003534:Cyproterone; D008234:Lynestrenol
Orale Kontraceptiva und Acne vulgaris.